Profile
Catherine Mallalieu
Partner / London
Practice & Professional Experience
Catherine is regularly recommended in independent legal publications. Legal 500 2011 stated: "On the life sciences side, Catherine Mallalieu is ‘very reliable' and has an 'excellent legal and scientific background’". In 2010 Catherine was referred to by Legal 500 as "‘excellent’ on pharmaceutical and biotech matters" (Legal 500 2010). Catherine has also been "singled out for praise" by Chambers in 2010 and is "clearly in the premier league of patent attorneys covering biotech in the UK" according to the Managing Intellectual Property (MIP) IP Handbook 2010.
Catherine has been successfully representing clients before the EPO since 1991 and has substantial experience in defending and opposing patents. In addition to multi-party oppositions, Catherine has taken a co-ordinating role in pan-European litigation.
As well as major international organisations, Catherine enjoys working directly with emerging companies and academic institutions to build value through their IP portfolio. This has often involved IP due diligence for mergers, project acquisitions and flotations. Catherine has a balanced portfolio across the chemical and biotechnological sectors.
Catherine had in-house patent experience with Zeneca Agrochemicals with particular responsibility for their bioscience division and in their insecticide division. Catherine became a partner at D Young & Co in 1997 and is a member of the Chartered Institute of Patent Attorney’s Patents Committee.
Qualifications
BSc in Chemistry, University of Birmingham.
European Patent Attorney 1991.
Chartered Patent Attorney 1991.
European Design Attorney.
Memberships
Chartered Institute of Patent Attorneys (CIPA) and the CIPA Patents Committee.
European Patent Institute (epi).
American Intellectual Property Law Association (AIPLA).
Selected Publications
Contributor to Chartered Institute of Patent Attorney’s European Patents Handbook.
